Plasma catalase activity and malondialdehyde level in patients with cataract

被引:22
作者
Ates, NA [1 ]
Yildirim, Ö
Tamer, L
Ünlü, A
Ercan, B
Muslu, N
Kanik, A
Hatungil, R
Atik, U
机构
[1] Mersin Univ, Tip Fak, Dept Med Biol & Genet, TR-33161 Mersin, Turkey
[2] Mersin Univ, Dept Ophthalmol, TR-33161 Mersin, Turkey
[3] Mersin Univ, Dept Biochem, TR-33161 Mersin, Turkey
[4] Mersin Univ, Dept Biostat, TR-33161 Mersin, Turkey
[5] Mersin Univ, Dept Physiol, TR-33161 Mersin, Turkey
关键词
cataract; catalase; malondialdehyde; oxidative stress;
D O I
10.1038/sj.eye.6700718
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose Oxidative mechanisms play a major role in the aetiology and pathogenesis of cataract, especially in age-related cataract. Our study aims to investigate systemic oxidant and antioxidant markers in cataract patients. Methods The activity of erythrocyte catalase and the level of malondialdehyde in plasma were measured in 40 patients with cataract and 60 healthy control subjects. The malondialdehyde level, as an index of lipid peroxidation, was determined by thiobarbituric acid reaction according to Yagi. The determination of catalase activity was measured by a method that was defined by Beutler. Catalase enzyme activity and malondialdehyde level were evaluated to find out whether there was a significant difference in these variables. Analysis of variance was used by forming a general linear model that takes age and gender as the covariate. Results CAT activity was found to be 13 920.2 +/- 847.9 U/l in cataract patients and 16 061.3 +/- 1126.6 U/l in control subjects. CAT activity in cataract patients was significantly lower than the control subjects (P = 0.008). Plasma MDA level is significantly higher in patients with cataract 4.47 +/- 7 0.35 nmol/ml compared to the control subjects 2.94 +/- 0.26 nmol/ml (P = 0.0001). There was no significant difference between different cataract subgroups when erythrocyte CAT activities and plasma MDA levels were compared (P = 0.322, 0.062). Conclusion This study shows that oxidant/antioxidant balances alter in the presence of cataract.
引用
收藏
页码:785 / 788
页数:4
相关论文
共 22 条
[1]  
Alberti G, 1996, INVEST OPHTH VIS SCI, V37, P1167
[2]   ANTIOXIDANT THERAPY IN THE TREATMENT OF EXPERIMENTAL ACUTE CORNEAL INFLAMMATION [J].
ALIO, JL ;
AYALA, MJ ;
MULET, ME ;
ARTOLA, A ;
RUIZ, JM ;
BELLOT, J .
OPHTHALMIC RESEARCH, 1995, 27 (03) :136-143
[3]  
ALIO JL, 1995, CORNEA, V14, P175
[4]  
BABIZHAEV MA, 1986, BIOFIZIKA+, V31, P109
[5]  
Behndig A, 1998, INVEST OPHTH VIS SCI, V39, P471
[6]  
BEUTLER E, 1975, RED CELL METABOLISM, P105
[7]   LENS OPACITIES CLASSIFICATION SYSTEM-II (LOCS-II) [J].
CHYLACK, LT ;
LESKE, MC ;
MCCARTHY, D ;
KHU, P ;
KASHIWAGI, T ;
SPERDUTO, R .
ARCHIVES OF OPHTHALMOLOGY, 1989, 107 (07) :991-997
[8]   SUPEROXIDE-DISMUTASE, CATALASE AND GLUTATHIONE-PEROXIDASE IN THE HUMAN CATARACTOUS LENS [J].
FECONDO, JV ;
AUGUSTEYN, RC .
EXPERIMENTAL EYE RESEARCH, 1983, 36 (01) :15-23
[9]   HISTOCHEMICAL-LOCALIZATION OF SUPEROXIDE PRODUCTION IN EXPERIMENTAL AUTOIMMUNE UVEITIS [J].
GRITZ, DC ;
MONTES, C ;
ATALLA, LR ;
WU, GS ;
SEVANIAN, A ;
RAO, NA .
CURRENT EYE RESEARCH, 1991, 10 (10) :927-931
[10]  
Hauet T, 1998, J PHARMACOL EXP THER, V285, P1061